John Bosso is a Rheumatology/Immunology physician affiliated with Hospital of the University of Pennsylvania. OpenAlex indexes 75 publications with 2,723 citations (h-index 19).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingIndustry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
1 company with payments on record in CMS Open Payments (2021 onward), matched to this physician's NPI. The itemized breakdown by company, amount and year is part of the full profile. Why? →
Medicare prescribing footprint (2023)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Respiratory
73.5%Corticosteroid25.9%Breo Ellipta31%Fluticasone Propionate18%Arnuity Ellipta15%Symbicort9%Trelegy Ellipta9%Budesonide-Formoterol Fumarate8%Flovent Hfa6%Dulera6%Part D<11 patientsLeukotriene Receptor Antagonist15.4%Montelukast Sodium100%Part D≥38 patients+ 5 more classes in this area
Dermatology
9.8%Interleukin-4 Receptor alpha Antagonist9.8%Dupixent Syringe56%Dupixent Pen44%Part D<11 patientsMetabolism & gastrointestinal
8.8%Corticosteroid8.8%Prednisone100%Part D≥43 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- The Completeness of Surgery Index Predicts Success in CRSwNP With Asthma by SNOT‐22 and Asthma Control Test
International Forum of Allergy & Rhinology
2025 - Factors influencing aspirin therapy after desensitization (ATAD) tolerance in aspirin-exacerbated respiratory disease (AERD) patients
Annals of Allergy Asthma & Immunology
2025 - Assessing adequacy of surgical extent in CRSwNP: The Completion of Surgery Index
International Forum of Allergy & Rhinology
2024 - Social factors associated with aspirin desensitization and diagnosis age in aspirin‐exacerbated respiratory disease
International Forum of Allergy & Rhinology
2024
Similar KOLs
Other experts from the same institution or the same specialty.
Mohamed Gad, MD, MPH
Hospital of the University of Pennsylvania
Lawrence Wechsler, MD
Hospital of the University of Pennsylvania
John Hirshfeld, MD
Hospital of the University of Pennsylvania
Noelle Frey, MD
Hospital of the University of Pennsylvania
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”